Alternatives to vyrarx

The price-first pick: some of the lowest flat, all-inclusive compounded pricing we track, nationwide — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.

• $4/mo cheaper than vyrarx
• serves all 50 states, where vyrarx lists Not stated on the site
• scores 80/100 against vyrarx's 34

The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.

• serves all 50 states, where vyrarx lists Not stated on the site
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.

• serves all 50 states, where vyrarx lists Not stated on the site
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

A clean, all-50-states compounded option with named pharmacies, no membership and the consult included — reasonable and transparent on price, though it's a newer platform with thin public detail beyond the $199 headline.

• serves all 50 states, where vyrarx lists Not stated on the site
• has an oral option if you would rather not inject
• scores 78/100 against vyrarx's 34

⛔ FDA warning letter #728279 (June 2026), which names tryeden.com. The most oversight-forward compounded program here — visible clinician involvement and lab framing — at $196/mo semaglutide or $296/mo tirzepatide, flat and nationwide.

• serves all 50 states, where vyrarx lists Not stated on the site
• scores 89/100 against vyrarx's 34

A science-forward compounded shop with a broad peptide catalog and flat dosing — $170/mo semaglutide, $210/mo tirzepatide ongoing — but the homepage 'as low as' price is a promotional rate, and there's no postpartum or PCOS-specific content.

• $9/mo cheaper than vyrarx
• serves all 50 states, where vyrarx lists Not stated on the site
• has an oral option if you would rather not inject

⛔ FDA warning letter #728291 (Jun. 2026), which names orderlymeds.com. One of the few sites in this round to publish real cash prices for both compounded ($149/mo semaglutide, $299/mo tirzepatide) and FDA-approved brand-name options (Wegovy® $1,839/mo, Zepbound® $1,498/mo) — a named Chief Medical Officer, licensed in all 50 states, though no content addresses postpartum or PCOS.

• $30/mo cheaper than vyrarx
• serves all 50 states, where vyrarx lists Not stated on the site
• offers FDA-approved brand pens, not just compounded

Both molecules have confirmed, tiered pricing, which appears only inside the signup flow — the public site carries no price at all — with a real gotcha: the 3-month plan costs more per month than month-to-month.

• serves all 50 states, where vyrarx lists Not stated on the site
• offers FDA-approved brand pens, not just compounded
• scores 71/100 against vyrarx's 34

A genuinely transparent tiered-pricing shop — as low as $149/mo semaglutide or $199/mo tirzepatide on the annual plan — with press mentions and bilingual support, though no postpartum or PCOS-specific content.

• $30/mo cheaper than vyrarx
• serves all 50 states, where vyrarx lists Not stated on the site
• has an oral option if you would rather not inject